ID: ALA1159981
Chembl Id: CHEMBL1159981
PubChem CID: 10468169
Max Phase: Preclinical
Molecular Formula: C9H18NO6P
Molecular Weight: 267.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(CP(=O)(O)CC[C@H](N)C(=O)O)C(=O)O
Standard InChI: InChI=1S/C9H18NO6P/c1-2-6(8(11)12)5-17(15,16)4-3-7(10)9(13)14/h6-7H,2-5,10H2,1H3,(H,11,12)(H,13,14)(H,15,16)/t6?,7-/m0/s1
Standard InChI Key: SEUYWUJYJFIGOY-MLWJPKLSSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 267.22 | Molecular Weight (Monoisotopic): 267.0872 | AlogP: 0.17 | #Rotatable Bonds: 8 |
| Polar Surface Area: 137.92 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 4 |
| #RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 1.73 | CX Basic pKa: 9.53 | CX LogP: -2.70 | CX LogD: -8.61 |
| Aromatic Rings: ┄ | Heavy Atoms: 17 | QED Weighted: 0.46 | Np Likeness Score: 0.73 |
| 1. Katoh M, Hiratake J, Kato H, Oda J. (1996) Mechanism-based inactivation of E. coli -glutamylcysteine synthetase by phosphinic acid- and sulfoximine-based transition-state analogues, 6 (13): [10.1016/S0960-894X(96)00247-8] |
Source(1):
